Review of Medication-Assisted Treatment Guidelines and Measures for Opioid and Alcohol Use

In response to the growing opioid epidemic, HHS announced a three-pronged initiative in March 2015 to: (1) improve opioid prescribing practices; (2) increase access to naloxone for overdose management; and (3) expand medication-assisted treatment (MAT) to reduce opioid dependence. In support of the initiative, ASPE contracted with Mathematica Policy Research to develop a roadmap that identifies concepts for potential quality measures that promote the appropriate use of MAT for opioid use, as well as the steps needed to develop those concepts into measures. As a guiding step in roadmap development, clinical MAT guidelines and existing measures related to MAT were reviewed. This report contains the review of clinical MAT guidelines and existing measures.